That Article's author must be feeling pretty influential about the power on his pen!
He writes a single article offering his views on ACTC and his words shake so many weak hands from the tree causing a large volume price decline. Maybe, though, it is a reflection less on his persuasive analysis and rather more on the weakness of the hands of those selling.
This article reminds me of the politico #$%$ on this MB. Someone writes a blog so the fringe element can spew their opinions and point to the blog as fact. The timing of this article is suspect imo. News is coming and big pharma (imo-NYT) is fighting against this new treatment that changes status quo. My opinion is a boiler room is orchestrating this. jmo